MicroVention, Inc.

Catheters are described that have improved flow characteristics that may be particularly helpful when delivering embolic agents within a blood vessel. One catheter includes a fluid flow modifier that is configured to create laminar fluid flow out of a distal end of the catheter to help reduce turbulence and achieve predictable fluid movement. Another catheter includes scavenging ports that are configured to suction in embolic agents that have refluxed proximally back from a distal end of the catheter.

A balloon catheter is described having a reinforced, co-axial, duel lumen design. In some embodiments, the balloon catheter includes a purging mechanism designed to purge air from the balloon.

Described herein is a braided stent having have a plurality of different segments that can reduce or eliminate foreshortening and allow the proximal end of the stent to more reliably open when deployed in a curved vessel. The segments can be connected together by interlocking loops positioned at the end of each segment and can be formed of one or more radially progressing wave patterns.

A stent with varying porosity is described. The stent can be comprised of multiple stents attached together. A braided stent may have selected regions of increased thickness. The stent may be comprised of wires that are welded together at their ends in order to minimize vessel trauma. The stent may comprise a helically wound radiopaque wire wound through the stent.

A medical device is disclosed and may have a spiral shape structure that can function as a stent, such as a flow diversion stent to treat aneurysms. The medical device may have a spiral shape structure that can function as an occlusive device, for instance to occlude aneurysms. The medical device may include a shape setting structure to selectively adjust the shape of the medical device.

Heart valve replacement often involves complications associated with paravalvular leaks. Vascular plug and occlusive devices, as well as heart valves particularly beneficial in treating the phenomenon of paravalvular leaks are described to address this issue.

Devices, systems, and methods used to seal a treatment area to prevent embolic agents from migrating are described. The concept has particular benefit in allowing liquid embolic to be used with a variety of intravascular therapeutic applications, including for occluding aneurysms and arteriovenous malformations in the neurovasculature.

Vascular device loading may be provided by loading a first liquid having a first density into a vascular device hub having an internal volume flowably connected between a syringe port and a cannula port; connecting a first syringe loaded with a second liquid to the syringe port, wherein the second liquid has a second density different than the first density; orienting the first syringe at a first elevation relative to the vascular device hub to place a denser one of the first liquid and the second liquid below a less dense one of the first liquid and the second liquid; and injecting, from the first syringe into the vascular device hub, the second liquid to eject the first liquid from the vascular device hub via the cannula port.

Microcatheters having enlarged distal ends with distally decreasing tapered portions are disclosed. These microcatheters can be used for various treatments within a vessel, such as treatment of a vasospasm and delivery of a liquid embolic material.

A balloon catheter is described with features to reduce balloon stickiness thereby ensuring a more even inflation profile. In some embodiments, a balloon guide catheter is described which includes a conduit or passage for additional catheters or devices.